TTNP Projected Dividend Yield
Com Par $0.011 New/Titan Pharmaceuticals Inc (DE) ( NASDAQ : TTNP )Titan Pharmaceuticals, Inc. is a pharmaceutical company. Co. is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix implant that is placed subdermally, normally in the inside part of the upper arm, in a brief procedure using a local anesthetic and is removed in a similar manner at the end of the treatment period. 21 YEAR PERFORMANCE RESULTS |
TTNP Dividend History Detail TTNP Dividend News TTNP Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |